We are a world leader in genomics research. We apply and explore genomic technologies to advance the understanding of biology and improve health 🧬
https://www.sanger.ac.uk/
Wellcome Sanger Institute
Loading...
Find out more about BASE Rx and Matt Coelho’s journey to co-founding the spin-out in our latest blog 👉 https://sangerinstitute.blog/2026/05/26/from-bases-to-breakthroughs-editing-cancers-weak-spots-with-crispr/
Sloths are the slowest mammals on the planet and now we know why. Scientists have sequenced the two-toed sloth genome and found ‘jumping genes’ linked to their extremely slow metabolism 🦥
Read more here ⤵️
https://www.sanger.ac.uk/news_item/why-are-sloths-so-slow-its-in-their-dna/
The programme will support BASE Rx as it develops faster, more effective approaches to cancer treatment, providing mentoring, workshops and investor support to help accelerate the company’s growth. 📈
The largest study of its kind focused on the healthy human gut microbiome is underway in Bangladesh. 🧬
Our latest blog follows Archana Madhav and her large-scale effort to study the human gut through stool samples. 💩
https://sangerinstitute.blog/2026/06/04/chasing-the-secrets-of-healthy-stool/
Read 'Cell-type-resolved genetic regulatory variation shapes inflammatory bowel disease risk' by @opentargets.org @sangerinstitute.bsky.social and @cuh.nhs.uk in @nature.com ⬇️
https://www.nature.com/articles/s41586-026-10627-z
We are launching a new AI consortium for genomics, in partnership with Google DeepMind and with support from Google.org. 🧬
The consortium will build large-scale, AI-ready genomic datasets to power breakthrough discoveries and advance biological research.
Read here 👇
bit.ly/3RTG6dK
Every discovery starts with reading 📚
From papers to datasets to code, our library helps turn knowledge into impact – powering open access and scientific discovery.
Read more 👉 https://sangerinstitute.blog/2026/06/11/how-our-library-powers-discovery-and-open-access/
Read ‘Elevated retrocopy burden and sloth-specific expansions illuminate mammalian genome evolution’ from the Sanger Institute, Leibniz Institute for Zoo and Wildlife Research (IZW), Hospital Sírio Libanês and others in @bmc.springernature.com, here: link.springer.com/article/10.1...
The largest cellular study of gut tissue reveals how differences in DNA influence the genes and pathways driving inflammatory bowel disease, pointing to new therapeutic targets. 🧬
Read the story below: 👇
https://bit.ly/3Qk4tAP
We’re pleased to announce that BASE Rx, a Sanger Institute spin-out looking to discover new cancer therapies, has been selected for the 2026 Accelerate@Babraham pre-seed programme. 👇
https://www.sanger.ac.uk/news_item/sanger-spin-out-secures-spot-on-game-changing-accelerator-programme/
